<?xml version="1.0" ?>
<document id="d672ce4063b2033261865d54cc7db91b9186beee">
  <chunk id="d672ce4063b2033261865d54cc7db91b9186beee.c0" text="Oroxylin-A Rescues LPS-Induced Acute Lung Injury via Regulation of NF-kB Signaling Pathway in Rodents">
    <entity charOffset="83-90" id="d672ce4063b2033261865d54cc7db91b9186beee.c0.e0" ontology_id="CHEBI_34922" text="Pathway" type="chemical"/>
  </chunk>
  <chunk id="d672ce4063b2033261865d54cc7db91b9186beee.c1" text="Background and Purpose: Successful drug treatment for sepsis-related acute lung injury (ALI) remains a major clinical problem. This study was designed to assess the beneficial effects of post-treatment of oroxylin A (OroA), a flavonoid, in ameliorating lipopolysaccharides (LPS)-induced lung inflammation and fatality.">
    <entity charOffset="35-39" id="d672ce4063b2033261865d54cc7db91b9186beee.c1.e0" ontology_id="CHEBI_23888" text="drug" type="chemical"/>
    <entity charOffset="205-215" id="d672ce4063b2033261865d54cc7db91b9186beee.c1.e1" ontology_id="CHEBI_61668" text="oroxylin A" type="chemical"/>
    <entity charOffset="253-272" id="d672ce4063b2033261865d54cc7db91b9186beee.c1.e2" ontology_id="CHEBI_16412" text="lipopolysaccharides" type="chemical"/>
    <pair e1="d672ce4063b2033261865d54cc7db91b9186beee.c1.e0" e2="d672ce4063b2033261865d54cc7db91b9186beee.c1.e1" id="d672ce4063b2033261865d54cc7db91b9186beee.c1.p0" relation="true"/>
    <pair e1="d672ce4063b2033261865d54cc7db91b9186beee.c1.e0" e2="d672ce4063b2033261865d54cc7db91b9186beee.c1.e2" id="d672ce4063b2033261865d54cc7db91b9186beee.c1.p1" relation="true"/>
    <pair e1="d672ce4063b2033261865d54cc7db91b9186beee.c1.e1" e2="d672ce4063b2033261865d54cc7db91b9186beee.c1.e2" id="d672ce4063b2033261865d54cc7db91b9186beee.c1.p2" relation="true"/>
  </chunk>
  <chunk id="d672ce4063b2033261865d54cc7db91b9186beee.c2" text="Experimental Approach: Rats were injected with LPS (10 mg/kg, iv) to induce ALI, and OroA was given (15 mg/kg, iv) 1 hr or 6 hrs after LPS challenge. Twenty four hrs after LPS challenge, biochemical changes in the blood and lung tissues, and morphological/histological alterations in the lung associated with inflammation and injury were examined. Therapeutic effect of OroA was assessed by measuring the survival rate in endotoxemic mice.">
    <entity charOffset="47-50" id="d672ce4063b2033261865d54cc7db91b9186beee.c2.e0" ontology_id="CHEBI_16412" text="LPS" type="chemical"/>
    <entity charOffset="135-138" id="d672ce4063b2033261865d54cc7db91b9186beee.c2.e1" ontology_id="CHEBI_16412" text="LPS" type="chemical"/>
    <entity charOffset="172-175" id="d672ce4063b2033261865d54cc7db91b9186beee.c2.e2" ontology_id="CHEBI_16412" text="LPS" type="chemical"/>
  </chunk>
  <chunk id="d672ce4063b2033261865d54cc7db91b9186beee.c3" text="Key Results: LPS (10 mg/kg, iv) significantly altered WBC counts, elevated plasma tumor necrosis factor (TNF)-a and nitric oxide (NO), increased pulmonary edema, thickened alveolar septa, and decreased survival rate. These changes were ameliorated by OroA (15 mg/kg, iv) administered 1 hr or 6 hrs after LPS challenge. This post-treatment also significantly attenuated LPS-induced activation of nuclear factor-kB (NF-kB) and the release of high mobility group box 1 (HMGB1) in lung tissues. Furthermore, post-treatment with OroA (60 mg/kg, ip) administered 1 hr or 6 hrs after LPS challenge in mice significantly increased survival rate.">
    <entity charOffset="13-16" id="d672ce4063b2033261865d54cc7db91b9186beee.c3.e0" ontology_id="CHEBI_16412" text="LPS" type="chemical"/>
    <entity charOffset="116-128" id="d672ce4063b2033261865d54cc7db91b9186beee.c3.e1" ontology_id="CHEBI_16480" text="nitric oxide" type="chemical"/>
    <entity charOffset="123-128" id="d672ce4063b2033261865d54cc7db91b9186beee.c3.e2" ontology_id="CHEBI_25741" text="oxide" type="chemical"/>
    <entity charOffset="304-307" id="d672ce4063b2033261865d54cc7db91b9186beee.c3.e3" ontology_id="CHEBI_16412" text="LPS" type="chemical"/>
    <entity charOffset="577-580" id="d672ce4063b2033261865d54cc7db91b9186beee.c3.e4" ontology_id="CHEBI_16412" text="LPS" type="chemical"/>
    <pair e1="d672ce4063b2033261865d54cc7db91b9186beee.c3.e0" e2="d672ce4063b2033261865d54cc7db91b9186beee.c3.e1" id="d672ce4063b2033261865d54cc7db91b9186beee.c3.p0" relation="true"/>
    <pair e1="d672ce4063b2033261865d54cc7db91b9186beee.c3.e0" e2="d672ce4063b2033261865d54cc7db91b9186beee.c3.e2" id="d672ce4063b2033261865d54cc7db91b9186beee.c3.p1" relation="true"/>
    <pair e1="d672ce4063b2033261865d54cc7db91b9186beee.c3.e1" e2="d672ce4063b2033261865d54cc7db91b9186beee.c3.e2" id="d672ce4063b2033261865d54cc7db91b9186beee.c3.p2" relation="true"/>
    <pair e1="d672ce4063b2033261865d54cc7db91b9186beee.c3.e1" e2="d672ce4063b2033261865d54cc7db91b9186beee.c3.e3" id="d672ce4063b2033261865d54cc7db91b9186beee.c3.p3" relation="true"/>
    <pair e1="d672ce4063b2033261865d54cc7db91b9186beee.c3.e1" e2="d672ce4063b2033261865d54cc7db91b9186beee.c3.e4" id="d672ce4063b2033261865d54cc7db91b9186beee.c3.p4" relation="true"/>
    <pair e1="d672ce4063b2033261865d54cc7db91b9186beee.c3.e2" e2="d672ce4063b2033261865d54cc7db91b9186beee.c3.e3" id="d672ce4063b2033261865d54cc7db91b9186beee.c3.p5" relation="true"/>
    <pair e1="d672ce4063b2033261865d54cc7db91b9186beee.c3.e2" e2="d672ce4063b2033261865d54cc7db91b9186beee.c3.e4" id="d672ce4063b2033261865d54cc7db91b9186beee.c3.p6" relation="true"/>
  </chunk>
  <chunk id="d672ce4063b2033261865d54cc7db91b9186beee.c4" text="Conclusion and Implication: OroA administered after induction of ALI by LPS significantly prevent and revere lung tissues injuries with increased survival rate. Positive post-treatment effects of OroA suggest that OroA is a potentially useful candidate for managing lung inflammation in LPS-induced endotoxemia and septic shock.">
    <entity charOffset="72-75" id="d672ce4063b2033261865d54cc7db91b9186beee.c4.e0" ontology_id="CHEBI_16412" text="LPS" type="chemical"/>
  </chunk>
</document>
